msadmin
New 3D AI eye model sharpens retinal disease detection and trial design
OCTCube-M reads full volumetric OCT scans to improve retinal disease detection, cut trial sizes and open a window to systemic…
Chai Discovery raises $400M at $3.8B valuation for AI drug design
The AI biotech startup triples its valuation in eight months with backing from Lilly, Pfizer and Novartis partnerships.
CMS signals payment reform for clinical software and AI
Medicare proposes a standardized payment structure for AI clinical tools based on patient outcomes.
Bipartisan senators probe Medicare Advantage AI care denials
Blumenthal and Hawley demand records from UnitedHealth, Humana and CVS on AI use to block rehabilitative care.
AI-powered biosimulation shakes up animal drug testing
Digital twins and multi-agent virtual scientists are accelerating the FDA's push to reduce animal testing.
AdvanCell raises $315 million for AI-driven radiotherapy
The Series D funds targeted alpha therapy for solid tumors using AI-powered isotope targeting.
AI predicts aggressive liver cancer subtype in 20 hospital study
A deep learning model predicts aggressive liver cancer from CT scans across 3,100 patients, potentially replacing biopsies for treatment selection.
Embedded transparency is key to equitable AI clinical trials
Researchers propose four pillars of embedded transparency to prevent AI bias from silently propagating through clinical trial infrastructure.